NeuroPrime Reviews: Announces U.S. Availability of Nine-Ingredient Liquid Dietary Supplement

New liquid formula combines Moringa, Pine Bark Extract, Ginkgo Biloba, Tamarind, Lion’s Mane Mushroom, Chlorella, Bacopa monnieri, Spirulina and Neem as the company publishes ingredient-level research context for consumers

MIAMI, FL, September 18, 2026 — NeuroPrime Research today announced the U.S. availability of NeuroPrime, a liquid dietary supplement formulated with Moringa, Pine Bark Extract, Ginkgo Biloba, Tamarind, Lion’s Mane Mushroom, Chlorella, Bacopa monnieri, Spirulina and Neem.

The commercial introduction expands the company’s presence in the cognitive-wellness supplement category with a liquid-drop format intended for adults seeking an alternative to conventional capsules and tablets. Alongside the product announcement, NeuroPrime Research is publishing additional information explaining the scientific literature associated with each listed ingredient and, importantly, the limitations of applying ingredient-level studies to a finished multi-ingredient supplement.

The company said the research material is being provided to help distinguish between published studies involving individual nutrients or botanical preparations and evidence specifically evaluating the complete NeuroPrime formula.

There is currently no clinical evidence cited by the company demonstrating that the finished NeuroPrime formulation produces the same outcomes observed in studies of isolated Moringa, Ginkgo Biloba, Bacopa monnieri, Lion’s Mane Mushroom or the remaining ingredients. Study formulations, ingredient amounts, participant characteristics and research durations can differ substantially from commercially available dietary supplements.

“Scientific references are most useful when they are presented with the appropriate context,” said a representative at NeuroPrime Research. “Our objective with this announcement is to identify what is in the formula, explain why those ingredients continue to appear in nutritional research, and remain clear that research on an individual ingredient is not the same as clinical evidence for a finished product.”

NeuroPrime Enters the Cognitive-Wellness Supplement Category

Interest in cognitive wellness has contributed to continued research into nutrition, physical activity and dietary components associated with normal memory function and neurological health.

Find more details about ingredients of NeuroPrime on their official website.

The National Center for Complementary and Integrative Health notes that a number of dietary supplements—including Ginkgo Biloba, Bacopa monnieri and Lion’s Mane Mushroom—have been studied in connection with memory-related measurements. However, NCCIH also emphasizes that the research is not strong or consistent enough to draw definitive conclusions for most dietary supplements, with studies differing considerably in formulation, dosage, population and methodology.

That distinction is relevant to NeuroPrime because the formula contains several ingredients that have individually attracted scientific attention.

The product combines botanical-derived ingredients—Moringa, Pine Bark Extract, Ginkgo Biloba, Tamarind, Lion’s Mane Mushroom, Chlorella, Bacopa monnieri, Spirulina and Neem—each with its own existing body of independent scientific literature.

Rather than representing those individual research findings as finished-product outcomes, NeuroPrime Research said the product announcement is intended to provide consumers with a clearer description of the formula and the scientific context surrounding its components.

Nine-Ingredient Formula Provides a Defined Product Profile

According to company product information, NeuroPrime contains nine principal ingredients:

• Moringa
• Pine Bark Extract
• Ginkgo Biloba
• Tamarind
• Lion’s Mane Mushroom
• Chlorella
• Bacopa monnieri
• Spirulina
• Neem

The ingredients are delivered in a liquid-drop format. The product is plant-based, non-GMO, contains no stimulants and no artificial chemicals.

The company has not provided individual ingredient quantities within the material reviewed for this announcement. Therefore, this release does not characterize NeuroPrime as providing amounts equivalent to those used in published clinical research.

This is an important limitation because study results cannot be evaluated solely on whether an ingredient’s name appears on a product label. Ingredient amount, preparation method, botanical standardization, formulation, study population and duration can all affect how research findings should be interpreted.

Ginkgo Biloba Has Been Examined Across Cognitive Research

Ginkgo Biloba is one of the most extensively studied botanical ingredients in the context of cognitive function and memory-related markers.

NCCIH reports that research involving Ginkgo Biloba has produced some potentially favorable findings relating to cognitive measurements, but it also cautions that existing studies have important limitations and differ in participant populations, supplement formulations, dosages and research duration. NCCIH therefore does not characterize the available evidence as establishing clear conclusions about dietary supplements for cognitive decline.

That qualification is particularly relevant when discussing a multi-ingredient commercial product.

Research involving a defined quantity of isolated Ginkgo Biloba cannot automatically establish what will occur when it is incorporated into another formulation at a different or undisclosed amount.

NeuroPrime Research therefore identifies Ginkgo Biloba as an ingredient with an existing scientific literature rather than claiming that studies involving isolated Ginkgo Biloba demonstrate an outcome from NeuroPrime itself.

Bacopa monnieri Research Includes Human Studies but Important Limitations

Bacopa monnieri is a botanical that has a history of traditional use and has also been investigated in modern clinical research relating to memory and cognitive performance.

Published systematic reviews have examined multiple studies involving Bacopa monnieri and reported changes in several memory-related measurements. However, such reviews have also identified substantial statistical heterogeneity across included studies, meaning results varied considerably among the research being evaluated.

Those findings provide scientific background concerning Bacopa monnieri but should not be interpreted as evidence for every supplement containing the botanical.

Different extracts can contain different concentrations of naturally occurring constituents, while research protocols can employ quantities and formulations that differ significantly from a commercial multi-ingredient product.

For NeuroPrime, Bacopa monnieri is therefore presented as one component of the formulation rather than as evidence of a clinically demonstrated finished-product effect.

Lion’s Mane Mushroom Has a Broad but Mixed Research Record

Lion’s Mane Mushroom is widely used as a functional food and has also been studied as a dietary supplement in connection with neurological and cognitive health.

Research findings concerning Lion’s Mane Mushroom and cognitive-related measurements have not been consistent.

NCCIH states that although studies have investigated Lion’s Mane—particularly in the context of cognitive function—the findings can be difficult to interpret because studies have used different species preparations, different portions, different quantities and different research methods.

NeuroPrime contains Lion’s Mane Mushroom as one of its nine listed ingredients. The company does not characterize the presence of Lion’s Mane Mushroom as evidence that the finished formula will reproduce findings reported in studies using specific preparations.

Tamarind Adds a Botanical Element to the Formula

Tamarind is a botanical ingredient with a long history of traditional culinary and medicinal use. Published research has explored its phytochemical composition and potential relevance to neurological health markers.

A published investigation supported by in vitro and in silico approaches examined the anti-cognitive decline potential of Tamarindus indica, noting findings relevant to neurological measurements. However, results from isolated ingredient studies should not be extrapolated to conclusions about a commercial multi-ingredient supplement.

Research involving isolated Tamarind preparations cannot automatically establish what will occur when it is incorporated into a multi-ingredient liquid formulation at a different or undisclosed amount.

Accordingly, the inclusion of Tamarind in NeuroPrime should be understood as part of the product’s botanical composition rather than as confirmation of a medical outcome.

Moringa, Pine Bark Extract, Chlorella, Spirulina and Neem Round Out the Formula

The remaining five ingredients—Moringa, Pine Bark Extract, Chlorella, Spirulina and Neem—each carry their own independent research histories in the context of nutritional science and general wellness.

Moringa has been studied for its broad nutritional profile. Pine Bark Extract has been examined for its antioxidant properties. Chlorella and Spirulina are algae-based ingredients that have attracted research interest for their nutrient density. Neem has a history of traditional botanical use and has also appeared in scientific literature.

As with the other listed ingredients, independent research concerning these botanicals should not be interpreted as clinical validation of the finished NeuroPrime multi-ingredient formula. Ingredient amount, extract preparation, standardization, formulation context and study population are all factors that affect how research findings should be applied.

Ingredient Studies Are Not Finished-Formula Studies

One of the central elements of NeuroPrime Research’s announcement is the distinction between ingredient research and product-specific evidence.

Scientific papers frequently study a single ingredient at a carefully defined amount under controlled conditions. A commercial dietary supplement may use another form, concentration or combination.

For a multi-ingredient formula, the presence of several individually researched components does not demonstrate that combining those ingredients will produce an additive, equivalent or enhanced result.

The company has not presented a randomized controlled clinical trial evaluating the complete NeuroPrime formula.

This means that published studies cited in connection with Ginkgo Biloba, Bacopa monnieri, Lion’s Mane Mushroom, Tamarind or the remaining ingredients should be interpreted as background literature concerning those ingredients.

They should not be presented as clinical validation of NeuroPrime.

That distinction also aligns with NCCIH guidance, which states that research surrounding supplements associated with cognitive function remains limited by variations in formulations, dosing, study populations and results.

“Consumers should be able to distinguish between an ingredient being scientifically studied and a specific commercial formula being clinically evaluated,” a NeuroPrime Research representative said. “Those are different standards of evidence. We believe clearly communicating that difference provides more useful information than simply attaching scientific citations to a product claim.”

Liquid Format Provides an Alternative Delivery Form

NeuroPrime is supplied as a liquid rather than a tablet or capsule. The format offers another delivery option for consumers who prefer liquid supplements as part of their routine. The company does not represent the liquid format itself as being more effective than capsules, tablets or other supplement formats.

Absorption and biological availability depend on factors including the ingredient, chemical form, formulation, concentration and individual characteristics. Without direct comparative research on NeuroPrime, no conclusion should be drawn that its liquid presentation produces superior absorption or outcomes.

The liquid bottle is therefore described principally as a product-format characteristic rather than a performance claim.

Responsible Use Remains Part of the Product Information

Dietary supplements are not appropriate for every individual, and botanical ingredients can interact with medications or existing medical conditions.

NCCIH advises people to discuss dietary supplements with a healthcare provider because supplements can interact with medicines and should not be used as replacements for established treatment.

Consumers using prescription medication, managing an existing medical condition, or considering multiple supplements should review the product label and discuss supplement use with an appropriately qualified healthcare professional.

NeuroPrime is a dietary supplement and is not positioned by the company as a substitute for professional medical evaluation, prescribed medication, nutrition, physical activity or other established elements of health management.

Regulatory and Research Transparency

The scientific references discussed in this announcement concern independent research involving individual ingredients.

Their inclusion does not mean the researchers, academic institutions, NIH, NCCIH or other cited organizations endorse NeuroPrime.

It also does not establish that the complete formula will produce outcomes identical to those described in individual ingredient studies.

Statements regarding dietary supplements have not been evaluated by the U.S. Food and Drug Administration. NeuroPrime is not intended to diagnose, treat, cure or prevent disease.

The company said future product communications will continue to distinguish general ingredient research from evidence specifically generated using the finished NeuroPrime formulation.

About NeuroPrime Research

NeuroPrime Research provides NeuroPrime, a liquid dietary supplement containing Moringa, Pine Bark Extract, Ginkgo Biloba, Tamarind, Lion’s Mane Mushroom, Chlorella, Bacopa monnieri, Spirulina and Neem. The company provides product information and scientific context concerning ingredients used in its formulation, with an emphasis on distinguishing independent ingredient research from product-specific evidence.

Additional product specifications, serving information and current availability should be confirmed through official NeuroPrime product materials.

Media & Corporate Communications Contact

NeuroPrime Research

Email: support@theneuroprime.com

Website: theneuroprime.com

Scientific References

National Center for Complementary and Integrative Health, “Ginkgo: Usefulness and Safety.” NCCIH reports that existing research does not clearly establish Ginkgo Biloba as effective for memory conditions and identifies significant variation among studies.

National Center for Complementary and Integrative Health, “Dietary Supplements for Cognitive Function, Dementia, and Alzheimer’s Disease: What You Need To Know.” NCCIH notes that studies of several supplements have produced some potentially favorable findings but that limitations and inconsistencies prevent clear conclusions.

National Institutes of Health Office of Dietary Supplements, “Dietary Supplements for Brain Health and Cognitive Function.” The fact sheet reviews botanical ingredients’ nutritional roles, research involving cognition and known medication-interaction considerations.

Elmaidomy AH, Abdelmohsen UR, Alsenani F, et al., “The anti-cognitive decline potential of Tamarindus indica: an in vivo investigation supported by in vitro and in silico approaches.” RSC Advances. 2022 Apr 19;12(19):11769–11785. doi: 10.1039/d2ra01340a. PMID: 35481086; PMCID: PMC9015909.

Hu, K., & Scheer, F. A. J. L. (2021). Could improving sleep protect against cognitive decline? Harvard Health Blog.

McCall, W. V. (2021). Melatonin, sleep, and cognitive decline. Harvard Health Blog. Harvard Health Publishing.

The post NeuroPrime Reviews: Announces U.S. Availability of Nine-Ingredient Liquid Dietary Supplement appeared first on 24 Health Times.